日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real‐world analysis from 20 US centers

纳武利尤单抗联合AVD方案作为经典型霍奇金淋巴瘤患者的一线治疗:来自美国20个中心的真实世界分析

Quinquenel, Anne; Aurran-Schleinitz, Thérèse; Clavert, Aline; Cymbalista, Florence; Dartigeas, Caroline; Davi, Frédéric; de Guibert, Sophie; Delmer, Alain; Dilhuydy, Marie-Sarah; Feugier, Pierre; Fornecker, Luc-Matthieu; Ghez, David; Guieze, Romain; Laribi, Kamel; Leblond, Véronique; Leprêtre, Stéphane; Letestu, Rémi; Lévy, Vincent; Nguyen-Khac, Florence; Michallet, Anne-Sophie; Tomowiak, Cécile; Tournilhac, Olivier; Ysebaert, Loïc; Troussard, Xavier; Bock, Allison M; Hao, Peirong; Xu, Yizhe; Luttwak, Efrat; Thiruvengadam, Swetha Kambhampati; Sekaran, Kanithra; Sano, Dahlia; Vaughn, John; Sharp, John; Major, Ajay; Patel, Vrutti; Smilnak, Gordon; Araujo, Nicole; Mynam, Ritwick; Reef, Daniel; Palmeri, Marisa; Gerber, Drew; Abhyankar, Anuja; Baek, Grace; Falade, Ayo; Iqbal, Madiha; Hu, Boyu; Geethakumari, Praveen Ramakrishnan; Durani, Urshila; Di, Mengyang; Niu, Alex; Cherng, Hua‐Jay J; Rhodes, Joanna M; Grover, Natalie; Pophali, Priyanka; Feldman, Tatyana; Shanmugasundaram, Krithika; Svoboda, Jakub; Voorhees, Timothy; Diefenbach, Catherine; Karimi, Yasmin; Karmali, Reem; Herrera, Alex F; Torka, Pallawi; Epperla, Narendranath

Measurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO group

在既往未接受治疗的中危慢性淋巴细胞白血病患者中,以可测量的残余病灶为指导,比较伊布替尼联合维奈克拉与FCR方案的疗效:一项来自FILO组的II期随机试验(ERADIC)。

Quinquenel, Anne; Letestu, Rémi; Le Garff-Tavernier, Magali; Morisset, Stéphane; Subtil, Fabien; Aurran, Thérèse; Laribi, Kamel; Cymbalista, Florence; Lévy, Vincent; Simon, Laurence; Roos-Weil, Damien; Leblond, Véronique; Dilhuydy, Marie-Sarah; Tomowiak, Cécile; Dartigeas, Caroline; Guièze, Romain; Tournilhac, Olivier; Ferrant, Emmanuelle; de Guibert, Sophie; Feugier, Pierre; Merabet, Fatiha; Leprêtre, Stéphane; Carassou, Philippe; Gay, Julie; Hivert, Bénédicte; Fornecker, Luc-Matthieu; Dupuis, Jehan; Molina, Lysiane; Villemagne, Bruno; Cartron, Guillaume; Drenou, Bernard; Mahé, Beatrice; Benbrahim, Omar; Cahu, Xavier; Portois, Christelle; Ysebaert, Loïc; Nguyen-Khac, Florence; Dahmani, Abdelmalek; Quiney, Claire; Rouillé, Valérie; Delmer, Alain; Michallet, Anne-Sophie

Sex Bias in IL-10 Production by Type I Regulatory T Cells Regulated by PI3K/mTOR Signaling

PI3K/mTOR信号通路调控I型调节性T细胞产生IL-10的性别差异

Debonlier, Aymeline; Kari, Saniya; Bucciarelli, Florence; Angles, Thibault; Perez-Pestel, Amelia; Fébrissy, Chanaëlle; Laffont, Sophie; Liblau, Roland; Lenfant, Françoise; Dunn, Shannon Elizabeth; Guillermet-Guibert, Julie; Astier, Anne L

The ganglioside GD3 and its synthase (ST8SIA1) as novel senescence markers associated with osteoarthritis.

神经节苷脂 GD3 及其合成酶 (ST8SIA1) 作为与骨关节炎相关的新型衰老标志物。

Fissoun Christina, Maroun Georges, Silva Raissa, Milano Margot, Guibert Benoit, Dagneaux Louis, Ferreira-Lopez Rosanna, Commes Thérèse, Gilson Eric, Jorgensen Christian, Cherfils-Vicini Julien, Pers Yves-Marie, Brondello Jean-Marc

Factors influencing front line treatment of chronic lymphocytic leukemia: A French real-world study

影响慢性淋巴细胞白血病一线治疗的因素:一项法国真实世界研究

Coste, Arthur; Sritharan, Nanthara; Lok, Anne; Tomowiak, Cécile; Ferrant, Emmanuelle; Clavert, Aline; Roos-Weil, Damien; Bouclet, Florian; Caillet, Adrien; Croizier, Carolyne; Stocker, Nicolas; Tchernonog, Emmanuelle; Feugier, Pierre; Santagostino, Alberto; Hivert, Bénédicte; Michallet, Anne-Sophie; De Guibert, Sophie; Lara, Diane; Waultier-Rascalou, Agathe; Merabet, Fatiha; Durand, Amandine; Bussot, Lucile; Laribi, Kamel; Dilhuydy, Marie-Sarah; Lévy, Vincent; Quinquenel, Anne

Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis

年龄和性别作为胶质瘤患者健康相关生活质量结局的风险因素:一项 CODAGLIO 2.0 分析

Asogwa, Ogechukwu A; Dirven, Linda; Aaronson, Neil K; Baumert, Brigitta G; van den Bent, Martin; Brandes, Alba A; Clement, Paul M; Coens, Corneel; Chinot, Olivier; Gorlia, Thierry; Herrlinger, Ulrich; Hertler, Caroline; Keime-Guibert, Florence; Rhun, Emilie Le; Lim, Luigi; Malmström, Annika; Marosi, Christine; Martinelli, Francesca; van der Meulen, Matthijs; Oliver, Kathy; Pace, Andrea; Panciroli, Claudia; Reijneveld, Jaap C; Renovanz, Mirjam; Roth, Patrick; Seidel, Clemens; Stupp, Roger; Wick, Wolfgang; Weller, Michael; Taphoorn, Martin J B; Koekkoek, Johan A F

Treatment preferences of patients receiving opioid agonist therapy in spain: a discrete choice experiment

西班牙接受阿片类激动剂治疗的患者的治疗偏好:一项离散选择实验

Dorado García, M L; Alonso Ganuza, Z; Henche Ruíz, A I; Marcos Flores, A; Orengo Caus, T; Palma Álvarez, R F; Rodríguez Cejas, M A; Sánchez Máñez, A; Vega Astudillo, P; Sucunza Guibert, D; Gómez-Barrera, M; Yébenes Cortés, M; Crespo Portero, A

One-year clinical, radiological, and functional outcomes following antifungal therapy for aspergillus infection in lung transplant recipients

肺移植受者接受抗真菌治疗治疗曲霉菌感染后一年的临床、放射学和功能性结果

Lelièvre, Ariane; Murris, Marlène; Dupuis, Marion; Mourlanette, Jean; Le Borgne, Aurélie; Collot, Samia; Marion, Olivier; Kamar, Nassim; Guibert, Nicolas; Villeneuve, Thomas

Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA

在初治慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者中,Zanubrutinib 与 Bendamustine 和 Rituximab 的疗效比较:SEQUOIA 研究的中位 5 年随访结果

Shadman, Mazyar; Munir, Talha; Robak, Tadeusz; Brown, Jennifer R; Kahl, Brad S; Ghia, Paolo; Giannopoulos, Krzysztof; Šimkovič, Martin; Österborg, Anders; Laurenti, Luca; Walker, Patricia A; Opat, Stephen S; Ciepluch, Hanna; Greil, Richard; Hanna, Merit; Tani, Monica; Trněný, Marek; Brander, Danielle; Flinn, Ian W; Grosicki, Sebastian; Verner, Emma; Tedeschi, Alessandra; de Guibert, Sophie; Tumyan, Gayane; Laribi, Kamel; García-Marco, José A; Li, Jian-Yong; Tian, Tian; Liu, Yu; Korolkiewicz, Roman; Szeto, Andy; Tam, Constantine S; Jurczak, Wojciech

A strong internal promoter drives massive expression of YEATS-domain devoid MLLT3 transcripts in HSC and most lethal AML

在造血干细胞和大多数致命性急性髓系白血病中,一种强效的内部启动子驱动着缺乏YEATS结构域的MLLT3转录本的大量表达。

Bessière, Chloé; Zamani, Ahmed; Pfeifer, Romain; Dailhau, Sandra; Marchet, Camille; Guibert, Benoit; Boureux, Anthony; Silva Da Silva, Raïssa; Gilbert, Nicolas; Commes, Thérèse; Meggetto, Fabienne; Touriol, Christian; Récher, Christian; Bousquet, Marina; Pyronnet, Stéphane